Publications

Filters: Author is Dubielzig, R R  [Clear All Filters]
Journal Article
Hershey AE, Dubielzig RR, Padilla ML, Helfand SC.  2005.  Aberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosis.. Veterinary pathology. 42(6):805-11. Abstract
Kurzman ID, MacEwen EG, Rosenthal RC, Fox LE, Keller ET, Helfand SC, Vail DM, Dubielzig RR, Madewell BR, Rodriguez CO.  1995.  Adjuvant therapy for osteosarcoma in dogs: results of randomized clinical trials using combined liposome-encapsulated muramyl tripeptide and cisplatin.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(12):1595-601. Abstract
Vail DM, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Kisseberth WC, London CA, Obradovich JE, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.. Clinical cancer research : an official journal of the American Association for Cancer Research. 1(10):1165-70. Abstract
Fox LE, MacEwen EG, Kurzman ID, Dubielzig RR, Helfand SC, Vail DM, Kisseberth W, London C, Madewell BR, Rodriguez CO.  1995.  Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine for the treatment of feline mammary adenocarcinoma--a multicenter randomized double-blind study.. Cancer biotherapy. 10(2):125-30. Abstract